CNTB

Connect Biopharma
CNTB

Overview Fund Activity

16 hedge funds and large institutions have $372M invested in Connect Biopharma in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 13 closing their positions.

Holders
16
Holders Change
-10
Holders Change %
-38.46%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
3
Increased
5
Reduced
4
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$137M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$76.7M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$29.9M
4
OWP
4
Old Well Partners
North Carolina
$2.39M
5
Millennium Management
5
Millennium Management
New York
$837K

Top Sellers

1
FCM
1
Farallon Capital Management
California
$0
2
CAM
2
Cormorant Asset Management
Massachusetts
$12.7M
3
Citadel Advisors
3
Citadel Advisors
Florida
$596K
4
LGM
4
Logos Global Management
California
$0
5
RSCM
5
Rock Springs Capital Management
Maryland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PCM
26
Pinz Capital Management
New York
– – -43,100 Closed
PHK
27
Point72 Hong Kong
Hong Kong
– – -10,426 Closed
ZP
28
Zimmer Partners
New York
– – -10,000 Closed
CSS
29
Cubist Systematic Strategies
Connecticut
– – -200 Closed
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
1
2